JP2019517990A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517990A5
JP2019517990A5 JP2018538746A JP2018538746A JP2019517990A5 JP 2019517990 A5 JP2019517990 A5 JP 2019517990A5 JP 2018538746 A JP2018538746 A JP 2018538746A JP 2018538746 A JP2018538746 A JP 2018538746A JP 2019517990 A5 JP2019517990 A5 JP 2019517990A5
Authority
JP
Japan
Prior art keywords
trichloroacetate
salt
aminolevulinic acid
benzyl
hexyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538746A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517990A (ja
JP6832358B2 (ja
Filing date
Publication date
Priority claimed from CN201610568868.0A external-priority patent/CN106187793A/zh
Application filed filed Critical
Publication of JP2019517990A publication Critical patent/JP2019517990A/ja
Publication of JP2019517990A5 publication Critical patent/JP2019517990A5/ja
Application granted granted Critical
Publication of JP6832358B2 publication Critical patent/JP6832358B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538746A 2016-01-26 2017-01-24 ５−アミノレブリン酸及び誘導体の塩 Active JP6832358B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662286977P 2016-01-26 2016-01-26
US62/286,977 2016-01-26
CN201610568868.0A CN106187793A (zh) 2016-01-26 2016-07-20 5‑氨基酮戊酸及其衍生物的盐化合物和应用
CN201610568868.0 2016-07-20
PCT/US2017/014791 WO2017132178A2 (en) 2016-01-26 2017-01-24 Salts of 5-aminolevulinic acid and derivatives

Publications (3)

Publication Number Publication Date
JP2019517990A JP2019517990A (ja) 2019-06-27
JP2019517990A5 true JP2019517990A5 (enExample) 2020-03-05
JP6832358B2 JP6832358B2 (ja) 2021-02-24

Family

ID=57493289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018538746A Active JP6832358B2 (ja) 2016-01-26 2017-01-24 ５−アミノレブリン酸及び誘導体の塩

Country Status (6)

Country Link
US (1) US10653653B2 (enExample)
EP (1) EP3408254B1 (enExample)
JP (1) JP6832358B2 (enExample)
CN (2) CN112010772A (enExample)
TW (1) TWI736577B (enExample)
WO (1) WO2017132178A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108937864A (zh) * 2018-06-05 2018-12-07 四川大学 口腔黏膜诱发荧光检测诊断仪
CN113677397A (zh) 2019-02-13 2021-11-19 阿尔菲斯医疗股份有限公司 无创声动力学治疗
WO2020229878A1 (es) * 2019-05-15 2020-11-19 Universidad De La Frontera Composición de uso tópico para terapia fotodinámica
AU2020282737A1 (en) 2019-05-29 2021-12-16 Sonalasense, Inc. Sonosensitization
CA3185803A1 (en) 2020-08-07 2022-02-10 Vijay Agarwal Ultrasound arrays for enhanced sonodynamic therapy for treating cancer
KR102265592B1 (ko) * 2020-10-29 2021-06-17 김진왕 5-아미노레불린산 수화염화물을 포함하는 조성물
WO2022100750A1 (zh) * 2020-11-16 2022-05-19 北京厚燊维康科技有限责任公司 可用于光动力治疗或诊断的制剂
US20220184234A1 (en) * 2020-11-30 2022-06-16 Sonalasense, Inc. Metabolic targeting of low grade tumors
JP2024526839A (ja) * 2021-07-20 2024-07-19 ピナクル バイオロジクス，インコーポレイテッド 光線力学療法組成物及びその療法での治療の方法
CN113620828B (zh) * 2021-08-17 2025-04-01 湖南复瑞生物医药技术有限责任公司 一种5-氨基酮戊酸酯化物、用途和农药组合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE397731A (enExample) 1932-07-21
US5273982A (en) * 1990-03-09 1993-12-28 Hoffmann-La Roche Inc. Acetic acid derivatives
CN1023338C (zh) * 1990-04-01 1993-12-29 张廷余 海洋波浪能发电装置
JP2896963B2 (ja) * 1994-11-28 1999-05-31 株式会社コスモ総合研究所 植物の耐塩性向上剤
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
DE122006000051I1 (de) 1995-03-10 2007-01-04 Photocure Asa Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
CA2206203A1 (en) 1997-05-27 1998-11-27 University Of British Columbia Photoactivation of endogenous porphyrins for treatment of psoriasis
FR2769626B1 (fr) * 1997-10-15 1999-12-03 Elf Aquitaine Exploration Prod Stabilisation de l'acide thioacetique
DE10003620A1 (de) 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
WO2003103603A2 (en) 2002-06-10 2003-12-18 Wyeth Novel formate salt of o-desmethyl-venlafaxine
US20040147501A1 (en) * 2002-07-08 2004-07-29 Dolmans Dennis E.J.G.J. Photodynamic therapy
WO2004093993A1 (en) 2003-04-23 2004-11-04 Qlt Inc. Hair growth
US20050124638A1 (en) * 2003-12-08 2005-06-09 Swayze Eric E. Benzimidazoles and analogs thereof as antivirals
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
PL1731500T3 (pl) 2004-03-30 2011-06-30 Cosmo Ala Co Ltd Sól fosforanowa kwasu 5-aminolewulinowego, sposób jej wytwarzania oraz jej zastosowanie
US7964630B2 (en) 2004-11-02 2011-06-21 Dsm Ip Assets B.V. Topical application agents against mimic and age-related wrinkles
US20070225518A1 (en) * 2006-03-22 2007-09-27 Zvi Malik 5-Aminolevulinic acid salts and their use
JP5645104B2 (ja) * 2010-05-24 2014-12-24 国立大学法人東京工業大学 アラレマイシン誘導体
PL2407151T3 (pl) * 2010-07-15 2020-04-30 Progressare Medinvest B.V. Kompozycja do leczenia zmian skórnych i/lub paznokci
US20120330216A1 (en) * 2011-06-24 2012-12-27 Saad Ibrahim Almohizea Methods and apparatus for skin rejuvenation
RU2482856C2 (ru) * 2011-08-05 2013-05-27 Общество С Ограниченной Ответственностью "Оксигон" Комплексное соединение 2-хлорпропионата цинка и 2-хлорпропионовой кислоты, фармацевтическая композиция для лечения заболеваний кожи, способ ее получения и способ лечения поражений кожи, ногтей и видимых слизистых
CN103889986B (zh) * 2011-09-30 2017-07-21 C&C新药研究所 新杂环衍生物及其应用
CN106110326A (zh) * 2011-10-12 2016-11-16 思佰益药业股份有限公司 移植器官的成活促进剂
RU2635563C2 (ru) 2012-08-03 2017-11-14 ФотоКьюэр АСА Соединения
CN103265444B (zh) * 2013-04-24 2014-11-05 浙江大学 一种5-氨基乙酰丙酸磷酸盐的结晶方法
CN104478991B (zh) * 2014-12-10 2018-06-19 深圳市维琪医药研发有限公司 一种新型多肽化合物及其制备方法和其医药应用

Similar Documents

Publication Publication Date Title
CY1122516T1 (el) Ετοιμες προς χρηση διατυπωσεις κετορολακης
JP2018518537A5 (enExample)
RU2014112319A (ru) Соединения и фармацевтические композиции для лечения вирусных инфекций
JP2021505614A5 (enExample)
JP2010504343A5 (enExample)
MA34819B1 (fr) Dérivés bicyclo[3.2.1]octylamide et leurs utilisations
MA29909B1 (fr) Derives de pyridazine
CN105473552B (zh) 用于产生吡咯衍生物及其中间体的方法
TNSN08408A1 (fr) PYRIDINE [3,4-b] PYRAZINONES
JP2010501474A5 (enExample)
PE20091317A1 (es) Antagonista del receptor opioide selectivo kappa
JP2009537554A5 (enExample)
ES2759312T3 (es) Compuestos de aminocarbonilcarbamato
EA201070747A1 (ru) Фармацевтический препарат, содержащий толперизон
JP2010090149A5 (enExample)
FI2629097T1 (fi) Nrf2-seulontatestejä ja niihin liittyviä menetelmiä ja koostumuksia
JP2018531273A5 (enExample)
JP2010505865A5 (enExample)
RU2012124332A (ru) Соли азилсартана с органическими аминами, способ их получения и применение
RU2008110644A (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
WO2021074284A1 (fr) Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes
AR063469A1 (es) Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades
MA28211A1 (fr) Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2103610A4 (en) SALTS OF IMIDAZOLE-5-CARBOXYLIC ACID DERIVATIVES, METHOD OF MANUFACTURE AND USE THEREOF